When planning your market access strategy, are you including the patient voice?
Can real-world evidence-based research help provide a patient-centric perspective when communicating the value of new treatments to payers?
Join Dr Louise Parmenter and Dr Stella Blackburn from Quintiles as they discuss the importance of embedding patient centricity into the development of real-world evidence in global market access strategies.
Key learning objectives
Who should attend
Market Access, Medical and Regulatory Affairs, Real-World Late Phase Research, Health Economics Outcomes Research, Brand Managers
Dr Louise Parmenter, Global Head of Operations, Epidemiology and Outcomes Research, Real-World and Late Phase at Quintiles
Dr Stella Blackburn, Vice President, Global Head of Risk Management, Real-World and Late Phase Research at Quintiles